A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

PHASE1CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

May 22, 2025

Study Completion Date

May 22, 2025

Conditions
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin
Interventions
DRUG

JNJ-67856633

JNJ-67856633 capsule will be administered orally.

Trial Locations (47)

2031

Scientia Clinical Research, Randwick

3000

Peter MacCallum Cancer Centre, Melbourne

3168

Monash Medical Centre, Clayton

6009

Linear Clinical Research Ltd, Nedlands

8916

Hosp. Univ. Germans Trias I Pujol, Badalona

10021

Weill Cornell Medicine, New York

10029

Icahn School of Medicine at Mount Sinai, New York

10065

Memorial Sloan Kettering Cancer Center, New York

11528

Alexandra General Hospital of Athens, Athens

20162

ASST Grande Ospedale Metropolitano Niguarda, Milan

28040

Hosp Univ Fund Jimenez Diaz, Madrid

28041

Hosp. Univ. 12 de Octubre, Madrid

28223

Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcón

31008

Clinica Univ. de Navarra, Pamplona

31059

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse

37007

Hosp Clinico Univ de Salamanca, Salamanca

37044

CHU Bretonneau, Tours

39008

Hosp. Univ. Marques de Valdecilla, Santander

40138

Azienda Opedaliero-Universitaria Policlinico Sant'orsola Malpighi di Bologna, Bologna

44093

CHU de Nantes hotel Dieu, Nantes

48149

Universitatsklinikum Munster, Münster

59037

Hopital Claude Huriez, Lille

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

68198

University of Nebraska Medical Center, Omaha

69495

Centre hospitalier Lyon-Sud, Pierre-Bénite

74047

Sheba Medical Center, Ramat Gan

75013

Groupe Hospitalier Pitie Salpetriere, Paris

75248

Institut Curie, Paris

77025

MD Anderson, Houston

89081

Universitatsklinikum Ulm, Ulm

91010

City of Hope, Duarte

91120

Hadassah Medical Center, Jerusalem

94805

Institut Gustave Roussy, Villejuif

300060

Tianjin Medical University Cancer Institute and Hospital, Tianjin

300320

Institute of Hematology & Blood Disease Hospital Chinese Academy of Medical Science, Tianjin

330006

The First Affiliated Hospital of NanChang University, Nanchang

Unknown

The First Affiliated Hospital of Xian Jiaotong University, Xi'an

104 0045

National Cancer Center Hospital, Chūōku

259-1193

Tokai University Hospital, Isehara

460-0001

National Hospital Organization Nagoya Medical Center, Nagoya

700 8558

Okayama University Hospital, Okayama

135 8550

The Cancer Institute Hospital of JFCR, Tokyo

03080

Seoul National University Hospital, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

08035

Hospital de Vall D'Hebron, Barcelona

EC1A 7BE

St Bartholomew's Hospital, London

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03900598 - A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) | Biotech Hunter | Biotech Hunter